Share

Pfizer CEO to pitch Astra deal

London - Pfizer chief executive Ian Read flew into London on Tuesday to pitch his planned $100bn takeover of rival British drugmaker AstraZeneca to government ministers and urge them not to obstruct the deal.

The British government has so far adopted a neutral stance on the matter - in part because Pfizer has yet to make a firm bid - but behind the scenes officials are warning Pfizer against making draconian research job cuts, industry sources said.

A spokesperson for the US company said Read was meeting a number of key "stakeholders" in Britain, but declined to give further details.

One person familiar with the situation said Read's agenda on Tuesday had included a visit to the Treasury, or finance ministry.

Finance Minister George Osborne has said any deal between Pfizer and AstraZeneca would be a "commercial matter between the companies", but he stressed the importance of science to Britain during a television interview on Tuesday.

"I want to see more British science," Osborne said.

Read, who studied chemical engineering in London in the early 1970s, knows he is stepping into politically dangerous territory with a deal that is designed to generate both big cost savings and lower tax bills.

Unions, the opposition Labour party and some scientists have already raised the alarm about a potential Pfizer takeover of Britain's second-biggest drugmaker, which employs nearly 7 000 people in Britain.

Read, however, said it would be a mistake for Britain to go down an interventionist path by trying to block the deal.

"The UK faces a choice," he told the Financial Times in an interview. "Do they focus on ensuring there is an educated workforce with the right incentives in place to attract investment or do they pick winners and losers."

Buying AstraZeneca would be the biggest ever foreign acquisition of a British company.

Pfizer insists it views Britain as an attractive location for both pharmaceutical research and manufacturing - helped by recent government tax incentives - but that it cannot make any firm commitments on future investment or jobs.

Pfizer already has a tarnished reputation in the eyes of some scientists after shuttering a large drug research site in Sandwich, southern England, where Viagra was invented with the loss of nearly 2 000 jobs three years ago.

The US drugs giant also faces political headwinds on the other side of the Atlantic, where US politicians are unhappy about its plans to move its tax base to Britain.

Pfizer's plan to merge the two companies into a UK holding company, while maintaining its operational headquarters in New York, would likely be the largest deal ever done that included such a so-called tax "inversion."

On the financial front, meanwhile, investors believe Pfizer will need to raise its suggested bid for AstraZeneca to more than $105bn and increase the proportion of cash in the offer to win its prize.

We live in a world where facts and fiction get blurred
Who we choose to trust can have a profound impact on our lives. Join thousands of devoted South Africans who look to News24 to bring them news they can trust every day. As we celebrate 25 years, become a News24 subscriber as we strive to keep you informed, inspired and empowered.
Join News24 today
heading
description
username
Show Comments ()
Rand - Dollar
19.09
-1.0%
Rand - Pound
24.06
-0.7%
Rand - Euro
20.58
-0.5%
Rand - Aus dollar
12.39
-0.3%
Rand - Yen
0.13
-0.9%
Platinum
894.64
-0.3%
Palladium
992.99
-0.9%
Gold
2,196.85
+0.1%
Silver
24.44
-0.8%
Brent Crude
86.09
-0.2%
Top 40
67,964
+0.4%
All Share
74,173
+0.4%
Resource 10
56,465
+1.4%
Industrial 25
103,617
+0.3%
Financial 15
16,480
-0.3%
All JSE data delayed by at least 15 minutes Iress logo
Company Snapshot
Editorial feedback and complaints

Contact the public editor with feedback for our journalists, complaints, queries or suggestions about articles on News24.

LEARN MORE
Government tenders

Find public sector tender opportunities in South Africa here.

Government tenders
This portal provides access to information on all tenders made by all public sector organisations in all spheres of government.
Browse tenders